| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 82540 |
|
736 |
722 |
$0.00 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
3,408 |
2,682 |
$0.00 |
| 99442 |
|
225 |
220 |
$0.00 |
| 86703 |
|
451 |
450 |
$0.00 |
| 82570 |
|
114 |
112 |
$0.00 |
| 80061 |
Lipid panel |
1,689 |
1,674 |
$0.00 |
| 85610 |
|
371 |
277 |
$0.00 |
| 80076 |
|
39 |
39 |
$0.00 |
| 86705 |
|
12 |
12 |
$0.00 |
| 86480 |
|
97 |
95 |
$0.00 |
| 3078F |
|
364 |
331 |
$0.00 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
91 |
86 |
$0.00 |
| 83970 |
|
12 |
12 |
$0.00 |
| 83540 |
|
37 |
37 |
$0.00 |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
131 |
63 |
$0.00 |
| 82274 |
|
43 |
43 |
$0.00 |
| 3077F |
|
31 |
30 |
$0.00 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
190 |
188 |
$0.00 |
| 77062 |
|
53 |
53 |
$0.00 |
| 91300 |
|
132 |
132 |
$0.00 |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
55 |
55 |
$0.00 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
28 |
28 |
$0.00 |
| 84100 |
|
28 |
25 |
$0.00 |
| 82565 |
|
12 |
12 |
$0.00 |
| 87522 |
Neg quan hep c or qual rna |
363 |
359 |
$0.00 |
| 80053 |
Comprehensive metabolic panel |
2,003 |
1,704 |
$0.00 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
2,207 |
1,806 |
$0.00 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
28 |
28 |
$0.00 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
296 |
288 |
$0.00 |
| 99443 |
|
489 |
472 |
$0.00 |
| 3079F |
|
38 |
37 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
5,682 |
4,622 |
$0.00 |
| 85027 |
|
576 |
557 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,276 |
2,247 |
$0.00 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,100 |
1,062 |
$0.00 |
| 81001 |
|
263 |
241 |
$0.00 |
| 82043 |
|
736 |
722 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
308 |
306 |
$0.00 |
| 92250 |
|
29 |
29 |
$0.00 |
| 84443 |
Thyroid stimulating hormone (TSH) |
103 |
102 |
$0.00 |
| 3075F |
|
74 |
71 |
$0.00 |
| 3044F |
|
153 |
153 |
$0.00 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,657 |
1,529 |
$0.00 |
| 82607 |
|
67 |
66 |
$0.00 |
| 87340 |
|
94 |
94 |
$0.00 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
222 |
219 |
$0.00 |
| 83735 |
|
497 |
371 |
$0.00 |
| 86706 |
|
105 |
105 |
$0.00 |
| 90656 |
|
28 |
28 |
$0.00 |
| 1111F |
|
84 |
78 |
$0.00 |
| 86141 |
|
24 |
24 |
$0.00 |
| 3074F |
|
275 |
258 |
$0.00 |
| 86780 |
|
38 |
38 |
$0.00 |
| 83550 |
|
12 |
12 |
$0.00 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
80 |
75 |
$0.00 |
| 90686 |
|
46 |
46 |
$0.00 |
| 85652 |
|
12 |
12 |
$0.00 |
| 82728 |
|
37 |
37 |
$0.00 |
| 86592 |
|
14 |
14 |
$0.00 |